A possible role of glucocorticoids: an intrinsic inhibitor of the cytotoxic activity of tumor necrosis factor

Jpn J Cancer Res. 1988 Mar;79(3):305-8. doi: 10.1111/j.1349-7006.1988.tb01591.x.

Abstract

The cytotoxic activity of tumor necrosis factor (TNF) against L929 fibroblasts in vivo was noncompetitively inhibited by physiological concentrations of glucocorticoids such as hydrocortisone (10(-7) M), corticosterone (5 X 10(-8) M) and dexamethasone (5 X 10(-9) M). The inhibition was abolished by the addition of actinomycin D (0.5 microgram/ml) or cycloheximide (4 microM). A phospholipase A2 inhibitor, quinacrine (2 X 10(-6) M), also inhibited the TNF cytotoxicity. These findings suggest that the antitumor cytotoxic reaction by TNF is regulated by glucocorticoid through some mechanism involving de novo transcription and translation and that this regulatory mechanism may involve inhibition of phospholipase A2 activity.

MeSH terms

  • Animals
  • Antineoplastic Agents / pharmacology
  • Antineoplastic Agents / physiology*
  • Cell Line
  • Cell Survival / drug effects*
  • Corticosterone / pharmacology
  • Glucocorticoids / pharmacology
  • Glucocorticoids / physiology*
  • Humans
  • Hydrocortisone / pharmacology
  • Mice
  • Quinacrine / pharmacology
  • Tumor Necrosis Factor-alpha / antagonists & inhibitors*

Substances

  • Antineoplastic Agents
  • Glucocorticoids
  • Tumor Necrosis Factor-alpha
  • Quinacrine
  • Corticosterone
  • Hydrocortisone